Howard Robin
Chief Executive Officer at NEKTAR THERAPEUTICS
Net worth: 1 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Chess | M | 66 | 33 years | |
| R. Greer | M | 65 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 21 years |
| Mark Wilson | M | 52 | 22 years | |
| Jennifer Ruddock | F | - | 20 years | |
| Sandra Gardiner | F | 58 | 1 years | |
| Mary Tagliaferri | M | 58 | 9 years | |
| Roy Whitfield | M | 70 | 24 years | |
| Myriam Curet | M | 67 | 5 years | |
| Jeff Ajer | M | 61 | 7 years | |
| Diana Brainard | M | 53 | 3 years | |
| Rosina B. Dixon | M | 81 |
Fairleigh Dickinson University
| - |
| Jim Ciprich | M | - |
Fairleigh Dickinson University
| 17 years |
| Robert Stewart | M | 56 |
Fairleigh Dickinson University
| 7 years |
| Gail Mandel | F | 55 |
Fairleigh Dickinson University
| - |
| Vivian Wu | F | - | 6 years | |
| Jonathan Zalevsky | M | 49 | 9 years | |
| Ami Simunovich | M | - |
Fairleigh Dickinson University
| - |
| Andrew Bluestone | M | - |
Fairleigh Dickinson University
| - |
| Carrie Boardwick | F | - |
Fairleigh Dickinson University
| - |
| Dan Cassino | M | - |
Fairleigh Dickinson University
| - |
| Robert J. Pures | M | - |
Fairleigh Dickinson University
| - |
| Anthony S. Cavalieri | M | - |
Fairleigh Dickinson University
| 48 years |
| Govi Rao | M | 61 |
Fairleigh Dickinson University
| - |
| Patrick Zenner | M | 77 |
Fairleigh Dickinson University
| - |
| Zhaobo Wang | M | 67 |
Fairleigh Dickinson University
| 32 years |
| Richard Cuccioli | M | - |
Fairleigh Dickinson University
| - |
| Matt Mustachio | M | - |
Fairleigh Dickinson University
| - |
| Gregory H. Olsen | M | - |
Fairleigh Dickinson University
| - |
| Stewart Krentzman | M | - |
Fairleigh Dickinson University
| - |
| Mark Rich | M | - |
Fairleigh Dickinson University
| - |
| Linda DeLukey Villa | F | 74 |
Fairleigh Dickinson University
| - |
| Robert J. Zatta | M | 74 |
Fairleigh Dickinson University
| - |
| Angeliki Frangou | F | 59 |
Fairleigh Dickinson University
| 9 years |
| Chris Cordaro | M | - |
Fairleigh Dickinson University
| - |
| Charles Klatskin | M | - |
Fairleigh Dickinson University
| - |
| Robert Bacci | M | - | 23 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gil Labrucherie | M | 52 | 17 years | |
| Lutz Lingnau | M | 81 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 14 years |
| Chris Christoffersen | M | 86 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 10 years |
| Bharatt Chowrira | M | 59 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 16 years |
| John Nicholson | M | 72 | 12 years | |
| John Stuart Patton | M | 77 | 18 years | |
| Nassim Usman | M | 64 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 13 years |
| Dorian L. Rinella | F | - |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | - |
| Fred Craves | M | 78 |
Berlex Laboratories, Inc.
| 3 years |
| Gabor M. Rubanyi | M | 77 |
Berlex Laboratories, Inc.
Berlex, Inc.
 Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | 11 years |
| Truc Le | M | - | 6 years | |
| Warren M. Krompf | M | - |
Fairleigh Dickinson University
| 7 years |
| Maninder Hora | M | 70 | 9 years | |
| Jillian Thomsen | F | 58 | 17 years | |
| Lorianne K. Masuoka | M | 62 |
Berlex Laboratories, Inc.
| 10 years |
| Brian Kotzin | M | 74 | 6 years | |
| Timothy Harkness | M | 57 | - | |
| Ho Young Huh | M | 54 | 1 years | |
| Dennis L. Winger | M | 77 | 9 years | |
| Christopher Kuebler | M | 70 | 17 years | |
| Joseph J. Krivulka | M | 73 | 13 years | |
| Karin Eastham | F | 74 | 5 years | |
| Susan S. Wang | F | 73 | 13 years | |
| Dennis Dwulet | M | - |
Fairleigh Dickinson University
| 4 years |
| Pamela A. Pavco | M | 67 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 4 years |
| John F. Fruhmann | M | - |
Fairleigh Dickinson University
| 2 years |
| Roberto Guerciolini | M | 69 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 2 years |
| Angus Douglass | M | 76 |
Fairleigh Dickinson University
| 4 years |
| Hope Remoundos | F | 70 |
Fairleigh Dickinson University
| 4 years |
| Robert A. Ollar | M | - |
Fairleigh Dickinson University
| 4 years |
| Lenard B. Tessler | M | 72 |
Fairleigh Dickinson University
| 2 years |
| John Joseph Lent | M | - |
Fairleigh Dickinson University
| 2 years |
| Saverio Garruto | M | 75 |
Fairleigh Dickinson University
| 4 years |
| Christine King | F | 74 |
Fairleigh Dickinson University
| 4 years |
| Mel Schrieberg | M | - |
Fairleigh Dickinson University
| 2 years |
| Norma Edmiston | F | - |
Fairleigh Dickinson University
| 4 years |
| Myron Bari | M | - |
Fairleigh Dickinson University
| 2 years |
| Richard Charles Wolfe | M | - |
Fairleigh Dickinson University
| 2 years |
| Mohamad Tabrizi | M | - | 10 years | |
| Ahmad Shahbari | M | - |
Fairleigh Dickinson University
| 2 years |
| Jeffrey R. Latts | M | 76 |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | 11 years |
| Hosen S. Marjaee | M | - |
Fairleigh Dickinson University
| 4 years |
| Edward J. Obuchowski | M | - |
Fairleigh Dickinson University
| 2 years |
| Richard Koseluk | M | - |
Fairleigh Dickinson University
| 4 years |
| Herman Ellman | M | 76 |
Berlex Laboratories, Inc.
| 5 years |
| Thomas P. Mac Mahon | M | 77 |
Fairleigh Dickinson University
| 2 years |
| Edward H. Cichurski | M | 82 |
Fairleigh Dickinson University
| 2 years |
| Edward Cowle | M | 67 |
Fairleigh Dickinson University
| 4 years |
| Michael Joseph Stavar | M | - |
Fairleigh Dickinson University
| 3 years |
| Carmine Catizone | M | 79 |
Fairleigh Dickinson University
| 4 years |
| Harold Stein | M | - |
Fairleigh Dickinson University
| 2 years |
| John Bingman | M | 72 |
Fairleigh Dickinson University
| 4 years |
| Ronald J. Doerfler | M | 83 |
Fairleigh Dickinson University
| 2 years |
| Robert A. Medv | M | 58 | 3 years | |
| William J. Rose | M | - |
Fairleigh Dickinson University
| 4 years |
| James Hattersley | M | 64 | 1 years | |
| Thomas C. Shepherd | M | 74 |
Fairleigh Dickinson University
| 4 years |
| Michael Stafford | M | - |
Fairleigh Dickinson University
| 1 years |
| Sean Casey | M | - |
Fairleigh Dickinson University
| 3 years |
| Martin Schmieg | M | 62 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 1 years |
| Steve Carson | M | - |
Fairleigh Dickinson University
| 2 years |
| Joe Rhyne | M | - |
Fairleigh Dickinson University
| 2 years |
| Linda H. Prentiss | F | 69 |
Fairleigh Dickinson University
| 4 years |
| Kuslima Shogen | F | 79 |
Fairleigh Dickinson University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Howard Robin
- Personal Network
